US FDA slams second Megafine facility in India with warning letter
A second Megafine Pharma plant has landed a US FDA warning letter for cGMP violations, including sourcing API intermediate materials from a facility on import alert.
Archives for March 8, 2017
Almac selected as preferred partner for EORTC clinical trials
Almac Diagnostics will initiate sample profiling on current EORTC trials to further biomarker discovery and development.
update
Ireland's HPRA did not recommend GMP cert renewal for Wockhardt Shendra plant
The Health Products Regulatory Authority of Ireland (HPRA) has said it did not recommend renewal of the GMP certificate for Wockhardt’s site in Shendra, Aurangabad.
CRO-less trial of malaria generic uses crowdfunding to treat bowel cancer
In the absence of a CRO, the 200 patient NeoART study is relying on the UK NHS, crowdfunding and charity to trial an antimalarial generic for late stage bowel cancer.
Opioid API firm Noramco moves into cannabinoids
Noramco has added cannabinoids to its portfolio of opioid APIs.
Clinerion rolls out recruitment services to countries in EEMEA
Clinerion has expanded its services into countries in Eastern Europe, the Middle East and Africa (EEMEA) following appointment of a new regional head.